| Year |
Citation |
Score |
| 2021 |
Bonner MA, Morales-Hernández A, Zhou S, Ma Z, Condori J, Wang YD, Fatima S, Palmer LE, Janke LJ, Fowler S, Sorrentino BP, McKinney-Freeman S. 3' UTR-truncated HMGA2 overexpression induces non-malignant expansion of hematopoietic stem cells in non-human primates. Molecular Therapy. Methods & Clinical Development. 21: 693-701. PMID 34141824 DOI: 10.1016/j.omtm.2021.04.013 |
0.411 |
|
| 2019 |
Ozog S, Timberlake ND, Hermann K, Garijo O, Haworth KG, Shi G, Glinkerman CM, Schefter LE, D'Souza S, Simpson E, Sghia-Hughes G, Carillo RR, Boger DL, Kiem HP, Slukvin I, ... ... Sorrentino BP, et al. Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes. Blood. PMID 31416800 DOI: 10.1182/Blood.2019000040 |
0.502 |
|
| 2019 |
Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, Ma Z, Condori J, Dowdy J, Triplett B, Li C, Maron G, Aldave Becerra JC, Church JA, Dokmeci E, ... ... Sorrentino BP, et al. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1. The New England Journal of Medicine. 380: 1525-1534. PMID 30995372 DOI: 10.1056/Nejmoa1815408 |
0.473 |
|
| 2018 |
Fatima S, Zhou S, Sorrentino BP. Marking of definitive HSC precursors in E7.5-E8.5 embryos using an Abcg2-CreER lineage tracing mouse model. Experimental Hematology. PMID 29964089 DOI: 10.1016/J.Exphem.2018.06.286 |
0.472 |
|
| 2017 |
Fukuda Y, Wang Y, Lian S, Lynch J, Nagai S, Fanshawe B, Kandilci A, Janke LJ, Neale G, Fan Y, Sorrentino BP, Roussel MF, Grosveld G, Schuetz JD. Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. Jci Insight. 2. PMID 28768907 DOI: 10.1172/Jci.Insight.92409 |
0.399 |
|
| 2017 |
Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross S, Ma Z, Dowdy J, Triplett B, Weiss MJ, Ryu BY, Dokmeci E, Aldave JC, Ravin SSD, Youngblood B, Long-Boyle JR, ... ... Sorrentino B, et al. Interim Results from a Phase I/II Clinical Gene Therapy Study for Newly Diagnosed Infants with X-Linked Severe Combined Immunodeficiency Using a Safety-Modified Lentiviral Vector and Targeted Reduced Exposure to Busulfan Blood. 130: 523-523. DOI: 10.1182/Blood.V130.Suppl_1.523.523 |
0.427 |
|
| 2016 |
De Ravin SS, Wu X, Moir S, Anaya-O'Brien S, Kwatemaa N, Littel P, Theobald N, Choi U, Su L, Marquesen M, Hilligoss D, Lee J, Buckner CM, Zarember KA, O'Connor G, ... ... Sorrentino BP, et al. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Science Translational Medicine. 8: 335ra57. PMID 27099176 DOI: 10.1126/Scitranslmed.Aad8856 |
0.441 |
|
| 2016 |
Zhou S, Fatima S, Ma Z, Wang YD, Lu T, Janke LJ, Du Y, Sorrentino BP. Evaluating the safety of retroviral vectors based on insertional oncogene activation and blocked differentiation in cultured thymocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26957223 DOI: 10.1038/Mt.2016.55 |
0.367 |
|
| 2016 |
Zhou S, Ma Z, Lu T, Brimble MA, Wang Y, Davidoff AM, Sorrentino BP. 571. Safe Harbor Targeting of IL2RG Expression Cassettes for Gene Therapy of X-Linked Severe Combined Immunodeficiency (SCID-X1) Molecular Therapy. 24: S228. DOI: 10.1016/S1525-0016(16)33379-2 |
0.488 |
|
| 2016 |
Bonner MA, Zhou S, Wang Y, Ma Z, Palmer L, Sorrentino BP. 281. Enforced Expression of a Mutant HMGA2 Gene Leads to Competitive Expansion and High Level Marking of Long-Term Hematopoietic Stem Cells in Transplanted Nemestrina Macaques Molecular Therapy. 24: S112-S113. DOI: 10.1016/S1525-0016(16)33090-8 |
0.557 |
|
| 2015 |
Doyle MJ, Maher TJ, Li Q, Garry M, Sorrentino BP, Martin CM. Abcg2 labeled cells contribute to different cell populations in the embryonic and adult heart. Stem Cells and Development. PMID 26573225 DOI: 10.1089/Scd.2015.0272 |
0.391 |
|
| 2015 |
Morfouace M, Cheepala S, Jackson S, Fukuda Y, Patel YT, Fatima S, Kawauchi D, Shelat AA, Stewart CF, Sorrentino BP, Schuetz JD, Roussel MF. ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy. Cancer Research. PMID 26199091 DOI: 10.1158/0008-5472.Can-15-0030 |
0.338 |
|
| 2015 |
Felsburg PJ, De Ravin SS, Malech HL, Sorrentino BP, Burtner C, Kiem HP. Gene therapy studies in a canine model of X-linked severe combined immunodeficiency. Human Gene Therapy. Clinical Development. 26: 50-6. PMID 25603151 DOI: 10.1089/humc.2015.004 |
0.409 |
|
| 2015 |
Zhou S, Bonner MA, Wang YD, Rapp S, De Ravin SS, Malech HL, Sorrentino BP. Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems. Human Gene Therapy Methods. 26: 4-12. PMID 25545666 DOI: 10.1089/hgtb.2014.122 |
0.312 |
|
| 2015 |
De Ravin SS, Wu X, Theobald N, Lee JS, Gray J, Hanson IC, Notarangelo L, Sorrentino BP, Malech HL. Lentiviral Hematopoietic Stem Cell Gene Therapy for Older Patients with X-Linked Severe Combined Immunodeficiency Blood. 126: 261-261. DOI: 10.1182/Blood.V126.23.261.261 |
0.514 |
|
| 2015 |
Choi U, Theobald N, Robert TE, Gray J, Rawlings DJ, Sorrentino BP, Malech H, De Ravin SS. High Titer Lentivector from a Stable Lenti-Producer Efficiently Corrects CD34+ Hematopoietic Stem Cells from Patients with p47phox-Deficient Chronic Granulomatous Disease Blood. 126: 2036-2036. DOI: 10.1182/Blood.V126.23.2036.2036 |
0.488 |
|
| 2015 |
Maciaszek JL, Treanor LM, Sorrentino BP. 445. A Delectable Lentiviral Vector System for Testing Oncogene Addiction in Hematological Malignancies Molecular Therapy. 23: S176-S177. DOI: 10.1016/S1525-0016(16)34054-0 |
0.528 |
|
| 2015 |
Fatima S, Zhou S, Wang Y, Ma Z, Du Y, Finkelstein D, Sorrentino BP. 291. A Novel Safety Assay for Retroviral Vectors That Reproduces Lmo2 Proto-Oncogene Insertional Activation Events Molecular Therapy. 23: S117. DOI: 10.1016/S1525-0016(16)33900-4 |
0.482 |
|
| 2015 |
Bonner M, Ma Z, Zhou S, Ren A, Chandrasekaran A, Gray JT, Sorrentino BP, Throm RE. 81. Development of a Second Generation Stable Lentiviral Packaging Cell Line in Support of Clinical Gene Transfer Protocols Molecular Therapy. 23: S35. DOI: 10.1016/S1525-0016(16)33686-3 |
0.43 |
|
| 2014 |
Yu H, Neale G, Zhang H, Lee HM, Ma Z, Zhou S, Forget BG, Sorrentino BP. Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo. Blood. 124: 1737-47. PMID 25082879 DOI: 10.1182/Blood-2013-10-534735 |
0.498 |
|
| 2014 |
Maher TJ, Ren Y, Li Q, Braunlin E, Garry MG, Sorrentino BP, Martin CM. ATP-binding cassette transporter Abcg2 lineage contributes to the cardiac vasculature after oxidative stress. American Journal of Physiology. Heart and Circulatory Physiology. 306: H1610-8. PMID 24727496 DOI: 10.1152/Ajpheart.00638.2013 |
0.32 |
|
| 2014 |
Treanor LM, Zhou S, Janke L, Churchman ML, Ma Z, Lu T, Chen SC, Mullighan CG, Sorrentino BP. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential. The Journal of Experimental Medicine. 211: 701-13. PMID 24687960 DOI: 10.1084/Jem.20122727 |
0.436 |
|
| 2014 |
De Ravin SS, Gray JT, Throm RE, Spindler J, Kearney M, Wu X, Coffin JM, Hughes SH, Malderelli F, Sorrentino BP, Malech HL. False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 244-5. PMID 24487563 DOI: 10.1038/Mt.2013.296 |
0.308 |
|
| 2013 |
Koldej RM, Carney G, Wielgosz MM, Zhou S, Zhan J, Sorrentino BP, Nienhuis AW. Comparison of insulators and promoters for expression of the Wiskott-Aldrich syndrome protein using lentiviral vectors. Human Gene Therapy. Clinical Development. 24: 77-85. PMID 23786330 DOI: 10.1089/Humc.2012.244 |
0.495 |
|
| 2013 |
Zhou S, Ma Z, Lu T, Janke L, Gray JT, Sorrentino BP. Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector. Plos One. 8: e62333. PMID 23626802 DOI: 10.1371/Journal.Pone.0062333 |
0.492 |
|
| 2013 |
O'Reilly M, Kohn DB, Bartlett J, Benson J, Brooks PJ, Byrne BJ, Camozzi C, Cornetta K, Crystal RG, Fong Y, Gargiulo L, Gopal-Srivastava R, High KA, Jacobson SG, Jambou RC, ... ... Sorrentino B, et al. Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012. Human Gene Therapy. 24: 355-62. PMID 23517518 DOI: 10.1089/Hum.2013.064 |
0.303 |
|
| 2013 |
Yasuda K, Cline C, Vogel P, Onciu M, Fatima S, Sorrentino BP, Thirumaran RK, Ekins S, Urade Y, Fujimori K, Schuetz EG. Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 923-31. PMID 23298861 DOI: 10.1124/Dmd.112.050344 |
0.37 |
|
| 2013 |
Treanor LM, Zhou S, Fukuda Y, Satish N, Finkelstein D, Schuetz JD, Mullighan CG, Sorrentino BP. N-Myc Is Overexpressed In Both Murine and Human Early T-Cell Precursor Leukemia and Is Sufficient To Initiate this Leukemia In Multipotent Primitive Arf-/- thymocytes Blood. 122: 348-348. DOI: 10.1182/Blood.V122.21.348.348 |
0.491 |
|
| 2012 |
Greene MR, Lockey T, Mehta PK, Kim YS, Eldridge PW, Gray JT, Sorrentino BP. Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line. Human Gene Therapy Methods. 23: 297-308. PMID 23075105 DOI: 10.1089/Hgtb.2012.150 |
0.453 |
|
| 2012 |
Sorrentino BP. Chemoprotection in brain tumor patients: another success for stem cell gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1485-7. PMID 22850719 DOI: 10.1038/Mt.2012.139 |
0.436 |
|
| 2012 |
Corrigan-Curay J, Cohen-Haguenauer O, O'Reilly M, Ross SR, Fan H, Rosenberg N, Somia N, King N, Friedmann T, Dunbar C, Aiuti A, Naldini L, Baum C, von Kalle C, Kiem HP, ... ... Sorrentino BP, et al. Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1084-94. PMID 22652996 DOI: 10.1038/Mt.2012.93 |
0.366 |
|
| 2012 |
Fatima S, Zhou S, Sorrentino BP. Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model. Stem Cells (Dayton, Ohio). 30: 210-21. PMID 22134889 DOI: 10.1002/Stem.1002 |
0.52 |
|
| 2011 |
Campbell PK, Zong Y, Yang S, Zhou S, Rubnitz JE, Sorrentino BP. Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia. Leukemia Research. 35: 1321-9. PMID 21640380 DOI: 10.1016/J.Leukres.2011.05.004 |
0.56 |
|
| 2011 |
Treanor LM, Volanakis EJ, Zhou S, Lu T, Sherr CJ, Sorrentino BP. Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. Blood. 117: 5453-62. PMID 21427293 DOI: 10.1182/Blood-2010-09-309831 |
0.361 |
|
| 2011 |
Jun D, Garat C, West J, Thorn N, Chow K, Cleaver T, Sullivan T, Torchia EC, Childs C, Shade T, Tadjali M, Lara A, Nozik-Grayck E, Malkoski S, Sorrentino B, et al. The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells (Dayton, Ohio). 29: 725-35. PMID 21312316 DOI: 10.1002/Stem.604 |
0.376 |
|
| 2011 |
Greene MR, Lockey T, Gray JT, Eldridge PW, Kim Y, Mehta PK, Sorrentino BP. Transduction of Human CD34+ Derived NSG Repopulating Cells with An Insulated SIN Lentiviral Vector for SCID-X1 From a Stable Producer Cell Line At Clinical Scale Blood. 118: 670-670. DOI: 10.1182/Blood.V118.21.670.670 |
0.456 |
|
| 2011 |
Treanor LM, Zhou S, Lu T, Mullighan CG, Sorrentino BP. Lmo2 Overexpression and Arf Loss Induce Myeloid Differentiation in Primitive Thymocytes Blood. 118: 47-47. DOI: 10.1182/Blood.V118.21.47.47 |
0.526 |
|
| 2011 |
Yu H, Zhou S, Neale GA, Sorrentino BP. Gene Expression Profiling of Murine HOXB4-Transduced HSCs Shows Multiple Counter-Regulatory Signals That May Control HSC Pool Size Blood. 118: 2361-2361. DOI: 10.1182/Blood.V118.21.2361.2361 |
0.511 |
|
| 2011 |
Zhou S, Fatima S, Sorrentino BP. Marking of Embryonic Precursors of Adult Hematopoietic Stem Cells At Gestational Day E7.5-E8.5 Using An Abcg2-CreERT2 Lineage Tracing Mouse Model Blood. 118: 1287-1287. DOI: 10.1182/Blood.V118.21.1287.1287 |
0.45 |
|
| 2010 |
Zhou S, Mody D, DeRavin SS, Hauer J, Lu T, Ma Z, Hacein-Bey Abina S, Gray JT, Greene MR, Cavazzana-Calvo M, Malech HL, Sorrentino BP. A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells. Blood. 116: 900-8. PMID 20457870 DOI: 10.1182/Blood-2009-10-250209 |
0.442 |
|
| 2010 |
Sorrentino B. Assessing the risk of T-cell malignancies in mouse models of SCID-X1. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 868-70. PMID 20436493 DOI: 10.1038/Mt.2010.69 |
0.498 |
|
| 2010 |
Jiang J, Yu H, Shou Y, Neale G, Zhou S, Lu T, Sorrentino BP. Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells. Blood. 116: 711-9. PMID 20393131 DOI: 10.1182/Blood-2009-07-235341 |
0.479 |
|
| 2010 |
Sorrentino BP. Scl and stem cell quiescence. Blood. 115: 751-2. PMID 20110428 DOI: 10.1182/Blood-2009-11-251264 |
0.412 |
|
| 2010 |
Treanor LM, Zhou S, Lu T, Sorrentino BP. Loss of p19Arf Increases the Self-Renewal Capacity of Immature Thymocytes That Over-Express LMO2 Blood. 116: 4198-4198. DOI: 10.1182/Blood.V116.21.4198.4198 |
0.491 |
|
| 2009 |
Larochelle A, Choi U, Shou Y, Naumann N, Loktionova NA, Clevenger JR, Krouse A, Metzger M, Donahue RE, Kang E, Stewart C, Persons D, Malech HL, Dunbar CE, Sorrentino BP. In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene. The Journal of Clinical Investigation. 119: 1952-63. PMID 19509470 DOI: 10.1172/Jci37506 |
0.516 |
|
| 2009 |
Cicero SA, Johnson D, Reyntjens S, Frase S, Connell S, Chow LM, Baker SJ, Sorrentino BP, Dyer MA. Cells previously identified as retinal stem cells are pigmented ciliary epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 6685-90. PMID 19346468 DOI: 10.1073/Pnas.0901596106 |
0.439 |
|
| 2009 |
Throm RE, Ouma AA, Zhou S, Chandrasekaran A, Lockey T, Greene M, De Ravin SS, Moayeri M, Malech HL, Sorrentino BP, Gray JT. Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection. Blood. 113: 5104-10. PMID 19286997 DOI: 10.1182/Blood-2008-11-191049 |
0.437 |
|
| 2007 |
Will E, Bailey J, Schuesler T, Modlich U, Balcik B, Burzynski B, Witte D, Layh-Schmitt G, Rudolph C, Schlegelberger B, von Kalle C, Baum C, Sorrentino BP, Wagner LM, Kelly P, et al. Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 782-91. PMID 17299409 DOI: 10.1038/Sj.Mt.6300083 |
0.478 |
|
| 2007 |
Zong Y, Zhou S, Sorrentino BP. Reply to 'Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels' by Widmer et al. [2] Leukemia. 21: 1562-1563. DOI: 10.1038/Sj.Leu.2404672 |
0.532 |
|
| 2006 |
Thrasher AJ, Gaspar HB, Baum C, Modlich U, Schambach A, Candotti F, Otsu M, Sorrentino B, Scobie L, Cameron E, Blyth K, Neil J, Abina SH, Cavazzana-Calvo M, Fischer A. Gene therapy: X-SCID transgene leukaemogenicity. Nature. 443: E5-6; discussion E6-. PMID 16988659 DOI: 10.1038/Nature05219 |
0.385 |
|
| 2006 |
Zong Y, Zhou S, Fatima S, Sorrentino BP. Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters. The Journal of Biological Chemistry. 281: 29625-32. PMID 16885162 DOI: 10.1074/Jbc.M606314200 |
0.631 |
|
| 2006 |
Shou Y, Ma Z, Lu T, Sorrentino BP. Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy. Proceedings of the National Academy of Sciences of the United States of America. 103: 11730-5. PMID 16864781 DOI: 10.1073/Pnas.0603635103 |
0.424 |
|
| 2006 |
Leggas M, Panetta JC, Zhuang Y, Schuetz JD, Johnston B, Bai F, Sorrentino B, Zhou S, Houghton PJ, Stewart CF. Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo. Cancer Research. 66: 4802-7. PMID 16651435 DOI: 10.1158/0008-5472.Can-05-2915 |
0.313 |
|
| 2006 |
Nienhuis AW, Dunbar CE, Sorrentino BP. Genotoxicity of retroviral integration in hematopoietic cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 1031-49. PMID 16624621 DOI: 10.1016/J.Ymthe.2006.03.001 |
0.463 |
|
| 2006 |
Tadjali M, Zhou S, Rehg J, Sorrentino BP. Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele. Stem Cells (Dayton, Ohio). 24: 1556-63. PMID 16484343 DOI: 10.1634/stemcells.2005-0562 |
0.422 |
|
| 2006 |
Seggewiss R, Pittaluga S, Adler RL, Guenaga FJ, Ferguson C, Pilz IH, Ryu B, Sorrentino BP, Young WS, Donahue RE, von Kalle C, Nienhuis AW, Dunbar CE. Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque. Blood. 107: 3865-7. PMID 16439674 DOI: 10.1182/Blood-2005-10-4108 |
0.519 |
|
| 2006 |
Zong Y, Zhou S, Sorrentino BP. Reply to Rumpold et al. Leukemia. 20: 144-145. PMID 16270041 DOI: 10.1038/Sj.Leu.2404002 |
0.454 |
|
| 2006 |
Stepanova L, Sorrentino B. “Side Population” Cells in Mouse Neuroblastoma Express Abcg2 and Are Enriched for Neuroblastoma Stem Cells. Blood. 108: 4268-4268. DOI: 10.1182/Blood.V108.11.4268.4268 |
0.447 |
|
| 2006 |
Jiang J, Shou Y, Sorrentino BP. Identifying Direct Targets of the Hoxb4 Transcription Factor Involved in Hematopoietic Cell Self Renewal. Blood. 108: 4190-4190. DOI: 10.1182/blood.v108.11.4190.4190 |
0.386 |
|
| 2006 |
Shou Y, Gray J, Agricola BA, Ma Z, Persons DA, Sorrentino BP. Retroviral Vector Integration Site Analysis in Rhesus Macaques Transplanted with Hematopoietic Stem Cells Transduced with Simian Immunodeficiency Virus Vectors. Blood. 108: 3255-3255. DOI: 10.1182/Blood.V108.11.3255.3255 |
0.398 |
|
| 2006 |
Zhou S, Fatima S, Sorrentino BP. Abcg2 Expression Marks Neural Stem Cells in the Murine Cerebellum. Blood. 108: 1674-1674. DOI: 10.1182/Blood.V108.11.1674.1674 |
0.501 |
|
| 2006 |
Tadjali M, Zhou S, Sorrentino BP. Expression of Abcg2 in Murine Skeletal Muscle Cells Identifies Two Populations with Different Myogenic Potential. Blood. 108: 1669-1669. DOI: 10.1182/Blood.V108.11.1669.1669 |
0.465 |
|
| 2006 |
Will E, Bailey J, Schuesler T, Balcik B, Burzynski B, Witte D, Layh-Schmitt G, vonKalle C, Baum C, Sorrentino BP, Wagner LM, Reeves L, Williams DA. 459. Murine Study To Evaluate Long-Term Transgene Expression of the MSCV-MGMTP140K wc Retroviral Vector in Support of a Phase I Gene Transfer Trial-Limitations of the Murine Model as a Pre-Clinical Tool Molecular Therapy. 13: S177-S178. DOI: 10.1016/J.Ymthe.2006.08.528 |
0.442 |
|
| 2006 |
Shou Y, Gray J, Agricola B, Ma Z, Nair GK, Stewart CF, Persons DA, Sorrentino BP. 69. Selection of Hematopoietic Progenitor and Stem Cells in Transplanted Rhesus Macaques Using MGMT and HOXB4 Lentiviral Vectors Molecular Therapy. 13: S29. DOI: 10.1016/J.Ymthe.2006.08.085 |
0.491 |
|
| 2005 |
Zong Y, Zhou S, Sorrentino BP. Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia. Leukemia. 19: 1590-6. PMID 16001089 DOI: 10.1038/Sj.Leu.2403853 |
0.609 |
|
| 2005 |
Stepanova L, Sorrentino BP. A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress. Blood. 106: 827-32. PMID 15692066 DOI: 10.1182/Blood-2004-06-2242 |
0.487 |
|
| 2005 |
McGaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science (New York, N.Y.). 307: 590-3. PMID 15681388 DOI: 10.1126/Science.1105160 |
0.356 |
|
| 2005 |
Zhou S, Zong Y, Ney PA, Nair G, Stewart CF, Sorrentino BP. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood. 105: 2571-6. PMID 15546952 DOI: 10.1182/Blood-2004-04-1566 |
0.615 |
|
| 2005 |
Zong Y, Zhou S, Sorrentino BP. Lineage-Specific Expression of Mouse Abcg2 during Hematopoiesis Is Regulated by Alternative Use of Multiple Leader Exons and Promoters. Blood. 106: 4251-4251. DOI: 10.1182/blood.v106.11.4251.4251 |
0.599 |
|
| 2005 |
Shou Y, Stepanova L, Sorrentino BP. An Accelerated Incidence of T-Cell Malignancies in a Mouse Model of XSCID Gene Therapy Is Associated with an Expanded Progenitor Cell Pool in the Bone Marrow. Blood. 106: 197-197. DOI: 10.1182/Blood.V106.11.197.197 |
0.509 |
|
| 2005 |
Tadjali M, Zhou S, Rehg J, Sorrentino BP. Relationship between ABCG2 Expression and Side Population Stem Cell Phenotype in Murine Hematopoietic System Revealed by an Abcg2/GFP Knock-In Mouse Model. Blood. 106: 1716-1716. DOI: 10.1182/Blood.V106.11.1716.1716 |
0.484 |
|
| 2005 |
Sorrentino BP. Improved human stem-cell transaction: The cat's meow Blood. 106: 8. DOI: 10.1182/Blood-2005-04-1498 |
0.433 |
|
| 2005 |
Shou Y, Gray J, Agricola B, Ma Z, Persons DP, Sorrentino BP. 1030. A Rhesus Macaque Transplant Model for Drug Selection of Hematopoietic Stem Cells Transduced with MGMT Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.577 |
0.505 |
|
| 2005 |
Shou Y, Stepanova L, Sorrentino BP. 454. Mouse Models for the Analysis of Genetic Risk Factors for Hematopoietic Transformation in XSCID Gene Therapy Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.462 |
0.493 |
|
| 2005 |
Seggewiss R, Pittaluga S, Adler R, Ferguson C, Vanin EF, Kelly PF, Donahue RE, Sorrentino BP, Nienhuis AW, Dunbar CE. 387. Myeloid Sarcoma Associated with Gene Marking of Hematopoietic Stem Cells in a Rhesus Macaque Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.390 |
0.486 |
|
| 2004 |
Sorrentino BP. Clinical strategies for expansion of haematopoietic stem cells. Nature Reviews. Immunology. 4: 878-88. PMID 15516967 DOI: 10.1038/Nri1487 |
0.421 |
|
| 2004 |
Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S, Mercer KE, Sarkadi B, Sorrentino BP, Schuetz JD. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. The Journal of Biological Chemistry. 279: 24218-25. PMID 15044468 DOI: 10.1074/Jbc.M313599200 |
0.479 |
|
| 2004 |
Kiem HP, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B, Bonifacino A, Hu J, von Kalle C, Schmidt M, Sorrentino B, et al. Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 389-95. PMID 15006605 DOI: 10.1016/J.Ymthe.2003.12.006 |
0.497 |
|
| 2004 |
Persons DA, Allay JA, Bonifacino A, Lu T, Agricola B, Metzger ME, Donahue RE, Dunbar CE, Sorrentino BP. Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors. Blood. 103: 796-803. PMID 12920024 DOI: 10.1182/Blood-2003-05-1572 |
0.504 |
|
| 2004 |
Tadjali M, Zhou S, Rehg J, Sorrentino BP. ABCG2 Expression as Prospective Marker for Hematopoeitic Stem Cell Purification. Blood. 104: 3212-3212. DOI: 10.1182/Blood.V104.11.3212.3212 |
0.534 |
|
| 2004 |
Stepanova L, Sorrentino BP. Expression of a HoxC4 Retroviral Vector Mediates Expansion of Murine Hematopoietic Stem Cells with Normal Hematopoiesis in Transplanted Mice. Blood. 104: 2788-2788. DOI: 10.1182/Blood.V104.11.2788.2788 |
0.554 |
|
| 2004 |
Shou Y, Stepanova L, Sorrentino B. Pharmacologic Control of HOXB4-Mediated Expansion of Murine Hematopoietic Stem Cells; Evidence for a Restricted Time Interval for Expansion. Blood. 104: 1689-1689. DOI: 10.1182/Blood.V104.11.1689.1689 |
0.455 |
|
| 2004 |
Sorrentino BP. One step closer to gene therapy for hemoglobinopathies Blood. 104: 3419-3419. DOI: 10.1182/Blood-2004-09-3516 |
0.345 |
|
| 2004 |
Stepanova L, Sorrentino BP. 634. The Role of Ink4a-Arf Locus in Control of Hematopoietic Stem Cell Proliferation Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.567 |
0.498 |
|
| 2004 |
Shou Y, Stepanova L, Sorrentino BP. 630. Tamoxifen-Inducible Expansion of Murine Hematopoietic Stem Cells by Retroviral-Mediated Transfer of a HOXB4-ERT2 Fusion Protein Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.560 |
0.527 |
|
| 2003 |
Zhou S, Zong Y, Lu T, Sorrentino BP. Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone. Biotechniques. 35: 1248-52. PMID 14682060 DOI: 10.2144/03356Ss04 |
0.596 |
|
| 2003 |
Sawai N, Persons DA, Zhou S, Lu T, Sorrentino BP. Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 376-84. PMID 12946310 DOI: 10.1016/S1525-0016(03)00205-3 |
0.483 |
|
| 2003 |
Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviére I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Brenner M, Cornetta K, et al. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 180-7. PMID 12907140 DOI: 10.1016/S1525-0016(03)00212-0 |
0.441 |
|
| 2003 |
Nienhuis AW, Hanawa H, Sawai N, Sorrentino BP, Persons DA. Development of gene therapy for hemoglobin disorders. Annals of the New York Academy of Sciences. 996: 101-11. PMID 12799288 DOI: 10.1111/J.1749-6632.2003.Tb03238.X |
0.496 |
|
| 2003 |
Persons DA, Allay ER, Sawai N, Hargrove PW, Brent TP, Hanawa H, Nienhuis AW, Sorrentino BP. Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells. Blood. 102: 506-13. PMID 12663444 DOI: 10.1182/Blood-2003-03-0677 |
0.5 |
|
| 2002 |
Abbott BL, Colapietro AM, Barnes Y, Marini F, Andreeff M, Sorrentino BP. Low levels of ABCG2 expression in adult AML blast samples. Blood. 100: 4594-601. PMID 12393637 DOI: 10.1182/Blood-2002-01-0271 |
0.316 |
|
| 2002 |
Zhou S, Morris JJ, Barnes Y, Lan L, Schuetz JD, Sorrentino BP. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proceedings of the National Academy of Sciences of the United States of America. 99: 12339-44. PMID 12218177 DOI: 10.1073/Pnas.192276999 |
0.534 |
|
| 2002 |
Sorrentino BP. Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs. Nature Reviews. Cancer. 2: 431-41. PMID 12189385 DOI: 10.1038/Nrc823 |
0.45 |
|
| 2002 |
Bunting KD, Bradley HL, Hawley TS, Moriggl R, Sorrentino BP, Ihle JN. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. Blood. 99: 479-87. PMID 11781228 DOI: 10.1182/Blood.V99.2.479 |
0.488 |
|
| 2001 |
Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine. 7: 1028-34. PMID 11533706 DOI: 10.1038/Nm0901-1028 |
0.513 |
|
| 2001 |
Donahue RE, Sorrentino BP, Hawley RG, An DS, Chen ISY, Wersto RP. Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34+ cells Molecular Therapy. 3: 359-367. PMID 11273778 DOI: 10.1006/Mthe.2001.0269 |
0.412 |
|
| 2001 |
Sellers SE, Tisdale JF, Agricola BA, Metzger ME, Donahue RE, Dunbar CE, Sorrentino BP. The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells. Blood. 97: 1888-91. PMID 11238136 DOI: 10.1182/Blood.V97.6.1888 |
0.511 |
|
| 2001 |
Sawai N, Zhou S, Vanin EF, Houghton P, Brent TP, Sorrentino BP. Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector Molecular Therapy. 3: 78-87. PMID 11162314 DOI: 10.1006/Mthe.2000.0223 |
0.532 |
|
| 2000 |
Bunting KD, Zhou S, Lu T, Sorrentino BP. Enforced P-glycoprotein pump function in murine bone marrow cells results in expression of side population stem cells in vitro and repopulating cells in vivo Blood. 96: 902-909. PMID 10910903 DOI: 10.1182/Blood.V96.3.902.015K40_902_909 |
0.529 |
|
| 2000 |
Giorgianni F, Bridson PK, Sorrentino BP, Pohl J, Blakley RL. Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3. Biochemical Pharmacology. 60: 325-38. PMID 10856427 DOI: 10.1016/S0006-2952(00)00344-0 |
0.439 |
|
| 2000 |
Patel DH, Allay JA, Belt JA, Sorrentino BP. Retroviral transfer of the hENT2 nucleoside transporter cDNA confers broad-spectrum antifolate resistance in murine bone marrow cells Blood. 95: 2356-2363. PMID 10733507 DOI: 10.1182/Blood.V95.7.2356.007K31_2356_2363 |
0.479 |
|
| 2000 |
Donahue RE, Wersto RP, Allay JA, Agricola BA, Metzger ME, Nienhuis AW, Persons DA, Sorrentino BP. High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34(+) cells. Blood. 95: 445-52. PMID 10627448 DOI: 10.1182/Blood.V95.2.445 |
0.479 |
|
| 2000 |
Bunting KD, Lu T, Kelly PF, Sorrentino BP. Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation Human Gene Therapy. 11: 2353-2364. DOI: 10.1089/104303400750038462 |
0.421 |
|
| 1999 |
Sorrentino BP, Allay JA, Blakley RL. In vivo selection of hematopoietic stem cells transduced with DHFR-expressing retroviral vectors. Progress in Experimental Tumor Research. 36: 143-61. PMID 10386071 DOI: 10.1159/000061994 |
0.488 |
|
| 1999 |
Bunting KD, Galipeau J, Topham D, Benaim E, Sorrentino BP. Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture Annals of the New York Academy of Sciences. 872: 125-141. PMID 10372117 DOI: 10.1111/J.1749-6632.1999.Tb08459.X |
0.531 |
|
| 1999 |
Bunting KD, Flynn KJ, Riberdy JM, Doherty PC, Sorrentino BP. Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency Proceedings of the National Academy of Sciences of the United States of America. 96: 232-237. PMID 9874801 DOI: 10.1073/Pnas.96.1.232 |
0.384 |
|
| 1999 |
Moscow JA, Huang H, Carter C, Hines K, Zujewski J, Cusack G, Chow C, Venzon D, Sorrentino B, Chiang Y, Goldspiel B, Leitman S, Read EJ, Abati A, Gottesman MM, et al. Engraftment of MDR1 and NeoR Gene-Transduced Hematopoietic Cells After Breast Cancer Chemotherapy Blood. 94: 52-61. DOI: 10.1182/Blood.V94.1.52.413K35_52_61 |
0.462 |
|
| 1999 |
Sorrentino BP, Nienhuis AW. 15 The Hematopoietic System as a Target for Gene Therapy Cold Spring Harbor Monograph Archive. 36: 351-426. DOI: 10.1101/087969528.36.351 |
0.447 |
|
| 1998 |
Allay JA, Galipeau J, Blakley RL, Sorrentino BP. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells. Stem Cells (Dayton, Ohio). 16: 223-33. PMID 11012166 DOI: 10.1002/Stem.5530160827 |
0.535 |
|
| 1998 |
Persons DA, Allay JA, Riberdy JM, Wersto RP, Donahue RE, Sorrentino BP, Nienhuis AW. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells. Nature Medicine. 4: 1201-5. PMID 9771757 DOI: 10.1038/2704 |
0.32 |
|
| 1998 |
Allay JA, Persons DA, Galipeau J, Riberdy JM, Ashmun RA, Blakley RL, Sorrentino BP. In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Medicine. 4: 1136-43. PMID 9771746 DOI: 10.1038/2632 |
0.547 |
|
| 1998 |
Bunting KD, Galipeau J, Topham D, Benaim E, Sorrentino BP. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice Blood. 92: 2269-2279. PMID 9746764 DOI: 10.1182/Blood.V92.7.2269.2269_2269_2279 |
0.537 |
|
| 1998 |
Mareya SM, Sorrentino BP, Blakley RL. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase. Cancer Gene Therapy. 5: 225-35. PMID 9694074 |
0.369 |
|
| 1998 |
Blakley RL, Sorrentino BP. In vitro mutations in dihydrofolate reductase that confer resistance to methotrexate: potential for clinical application. Human Mutation. 11: 259-63. PMID 9554740 DOI: 10.1002/(Sici)1098-1004(1998)11:4<259::Aid-Humu1>3.0.Co;2-W |
0.441 |
|
| 1998 |
Bunting KD, Sangster MY, Ihle JN, Sorrentino BP. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nature Medicine. 4: 58-64. PMID 9427607 DOI: 10.1038/Nm0198-058 |
0.473 |
|
| 1997 |
Patel M, Sleep SE, Lewis WS, Spencer HT, Mareya SM, Sorrentino BP, Blakley RL. Comparison of the protection of cells from antifolates by transduced human dihydrofolate reductase mutants. Human Gene Therapy. 8: 2069-77. PMID 9414255 DOI: 10.1089/Hum.1997.8.17-2069 |
0.377 |
|
| 1997 |
Galipeau J, Benaim E, Spencer HT, Blakley RL, Sorrentino BP. A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs. Human Gene Therapy. 8: 1773-83. PMID 9358027 DOI: 10.1089/Hum.1997.8.15-1773 |
0.463 |
|
| 1997 |
Allay JA, Spencer HT, Wilkinson SL, Belt JA, Blakley RL, Sorrentino BP. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors. Blood. 90: 3546-54. PMID 9345038 DOI: 10.1182/Blood.V90.9.3546 |
0.451 |
|
| 1997 |
Bunting KD, Webb M, Giorgianni F, Galipeau J, Blakley RL, Townsend AJ, Sorrentino BP. Coding region-specific destabilization of mRNA transcripts attenuates expression from retroviral vectors containing class 1 aldehyde dehydrogenase cDNAs. Human Gene Therapy. 8: 1531-43. PMID 9322086 DOI: 10.1089/Hum.1997.8.13-1531 |
0.426 |
|
| 1997 |
Persons DA, Allay JA, Allay ER, Smeyne RJ, Ashmun RA, Sorrentino BP, Nienhuis AW. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood. 90: 1777-86. PMID 9292510 DOI: 10.1182/Blood.V90.5.1777 |
0.52 |
|
| 1996 |
Benaim E, Sorrentino BP. Gene therapy in pediatric oncology Investigational New Drugs. 14: 87-99. PMID 8880396 DOI: 10.1007/Bf00173685 |
0.423 |
|
| 1996 |
Spencer HT, Sorrentino BP, Pui CH, Chunduru SK, Sleep SE, Blakley RL. Mutations in the gene for human dihydrofolate reductase: an unlikely cause of clinical relapse in pediatric leukemia after therapy with methotrexate. Leukemia. 10: 439-46. PMID 8642859 |
0.303 |
|
| 1996 |
Spencer HT, Sleep SE, Rehg JE, Blakley RL, Sorrentino BP. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood. 87: 2579-87. PMID 8630426 DOI: 10.1182/Blood.V87.6.2579.Bloodjournal8762579 |
0.476 |
|
| 1996 |
Sorrentino BP, Spencer HT, Blaklev RL, Allav JA. Protection of hematopoietic cells from antifolate toxicity by a novel variant of human dihydrofolate reductase Experimental Hematology. 24: 1157. |
0.432 |
|
| 1995 |
Brenner MK, Cunningham JM, Sorrentino BP, Heslop HE. Gene transfer into human hemopoietic progenitor cells British Medical Bulletin. 51: 167-191. PMID 7767642 DOI: 10.1093/Oxfordjournals.Bmb.A072945 |
0.51 |
|
| 1995 |
Sorrentino BP, McDonagh KT, Woods D, Orlic D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice Blood. 86: 491-501. PMID 7605985 DOI: 10.1182/Blood.V86.2.491.Bloodjournal862491 |
0.517 |
|
| 1995 |
Orlic D, Anderson S, Biesecker LG, Sorrentino BP, Bodine DM. Pluripotent hematopoietic stem cells contain high levels of mRNA for c- kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7 Proceedings of the National Academy of Sciences of the United States of America. 92: 4601-4605. PMID 7538677 DOI: 10.1073/Pnas.92.10.4601 |
0.345 |
|
| 1994 |
O'Shaughnessy JA, Cowan KH, Nienhuis AW, McDonagh KT, Sorrentino BP, Dunbar CE, Chiang Y, Wilson W, Goldspiel B, Kohler D. Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Human Gene Therapy. 5: 891-911. PMID 7526902 DOI: 10.1089/Hum.1994.5.7-891 |
0.401 |
|
| 1994 |
Dunbar CE, Bodine DM, Sorrentino B, Donahue R, McDonagh K, Cottler-Fox M, O'Shaughnessy J, Cowan K, Carter C, Doren S, Cassell A, Nienhuis AW, Brenner MK. Gene transfer into hematopoietic cells. Implications for cancer therapy Annals of the New York Academy of Sciences. 716: 216-224. PMID 7517651 DOI: 10.1111/J.1749-6632.1994.Tb21714.X |
0.4 |
|
| 1993 |
O'Shaughnessy JA, Cowan KH, Wilson W, Bryant G, Goldspiel B, Gress R, Nienhuis AW, Dunbar C, Sorrentino B, Stewart FM. Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer. Human Gene Therapy. 4: 331-54. PMID 8338880 DOI: 10.1089/Hum.1993.4.3-331 |
0.367 |
|
| 1993 |
Dunbar CE, Nienhuis AW, Stewart FM, Quesenberry P, O'Shaughnessy J, Cowan K, Cottler-Fox M, Leitman S, Goodman S, Sorrentino BP. Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer. Human Gene Therapy. 4: 205-22. PMID 8098622 DOI: 10.1089/Hum.1993.4.2-205 |
0.413 |
|
| 1992 |
Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1 Science. 257: 99-103. PMID 1352414 DOI: 10.1126/Science.1352414 |
0.475 |
|
| 1990 |
Sorrentino B, Ney P, Bodine D, Nienhius AW. A 46 base pair enhancer sequence within the locus activating region is required for induced expression of the gamma-globin gene during erythroid differentiation. Nucleic Acids Research. 18: 2721-31. PMID 2339058 DOI: 10.1093/Nar/18.9.2721 |
0.399 |
|
| Show low-probability matches. |